Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Cardiex Completes Placement & Launches Entitlement Offer

May 30, 2025

Pinnacle Closes Oversubscribed Non-Brokered Private Placement

August 8, 2025

Eby Unveils Northwest BC Mining Plan Amid Backlash...

May 28, 2025

WGC: Gold Demand Reaches Highest Q1 Level Since...

May 1, 2025

Secondary Trading Notice

April 3, 2025

Crypto Market Update: Bitcoin ETFs Shed US$1.46 Billion...

August 7, 2025

Alvopetro Announces Q2 2025 Financial Results and an...

August 7, 2025

Gold Rally Sparks Renewed Investor Rush Into Mining...

April 17, 2025

US Capital Gains Tax Guide for Gold and...

April 18, 2025

Element79 Gold Corp Welcomes Michael Smith as Vice...

July 22, 2025